Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 1, 2008BiochemistryOpen Access

Using a 3-O-Sulfated Heparin Octasaccharide To Inhibit the Entry of Herpes Simplex Virus Type 1

View Full Paper
Ask AI
Bookmark
Share

Authors

RCRonald J. CopelandUniversity of North Carolina at Chapel HillABArun BalasubramaniamEmory UniversityVTVaibhav TiwariMidwestern University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Copeland et al. (2008) studied this question.

synapsesocial.com/papers/6a93310e602aa564b2f8e7f7https://doi.org/10.1021/bi800205t
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role for 3- O -Sulfated Heparan Sulfate as the Receptor for Herpes Simplex Virus Type 1 Entry into Primary Human Corneal Fibroblasts2006 · 126 citations
  2. 2Infections with Herpes Simplex Viruses1986 · 778 citations
  3. 3Enzymatic Redesigning of Biologically Active Heparan Sulfate2005 · 125 citations